ZURICH/BERLIN, Nov 29 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
ROCHE ROG.S
Celltrion's 068270.KS Truxima became the first biosimilar
to Roche's $7-billion-per-year cancer drug Rituxan to be
approved in the United States to treat non-Hodgkin's lymphoma.
urn:newsml:reuters.com:*:nL4N1Y351O
COMPANY STATEMENTS E-CH
* Zur Rose ROSEG.S : Bookrunner says price guidance 90-95
francs per share, books covered throughout. ROSEG.S
* Cosmo Pharmaceuticals COPN.S : launch of offering of
senior unsecured convertible bonds due 2023. COPN.S
* Aevis Victoria AEVS.S : 9M net revenues (medical fees
excluded) amounted to 411.3 million francs. AEVS.S
ECONOMY M-CH
Third-quarter GDP data due at 0545 GMT
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit:
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German................ .SDE
All SMI constituent stocks............................ 0#.SSMI
News on major Swiss stock price moves.................. CH-HOT
FTSE Eurotop 300 index................................ .FTEU3
DJ STOXX index........................................ .STOXX
Top 10 STOXX sectors............................. .PGL.STOXXS
Top 10 EUROSTOXX sectors........................ .PGL.STOXXES
Top 10 Eurotop 300 sectors....................... .PGL.FTEU3S
Top 25 European pct gainers... .PG.PEUR , losers... .PL.PEUR
Swiss mid-cap index .SSMI SMI futures 0#SMI:
Swiss all-share index .SSHI Market statistics CH/STATS1
Swiss market digest .AD.S Sector overview CH/SECTOR1
All Swiss news CH Swiss research news CH-RCH
All equity news E
INTERNET ADDRESSES:
Swiss Exchange www.swx.ch/
STOXX Ltd www.stoxx.com
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY
SWITZERLAND REUTERS ))